Thom Bettridge to Step Down as I-D Editor in Chief
Global editorial director Steff Yotka will succeed Bettridge, who is leaving to focus on his creative studio Content World.

The move is a major reversal in strategy after Burberry took its beauty business in-house four years ago.

The move is a major reversal in strategy after Burberry took its beauty business in-house four years ago.

The family investment arm of Diesel founder Renzo Rosso has acquired a “high single digit” stake in the multi-sales platform Tomorrow London.

The family investment arm of Diesel founder Renzo Rosso has acquired a “high single digit” stake in the multi-sales platform Tomorrow London.

Costco, the retail industry's wunderkind, seems to be falling from grace.

Costco, the retail industry's wunderkind, seems to be falling from grace.

More and more emerging fashion designers are adopting a direct-to-consumer model, wooed by the promise of higher margins and a closer relationship with the customer. Can they really do without wholesale?

More and more emerging fashion designers are adopting a direct-to-consumer model, wooed by the promise of higher margins and a closer relationship with the customer. Can they really do without wholesale?
Global editorial director Steff Yotka will succeed Bettridge, who is leaving to focus on his creative studio Content World.
The athletic apparel maker is struggling with weak consumer demand amid macroeconomic uncertainty in its key North American market.
The luxury arm of Reliance Retail will operate the Skims brand across physical and digital channels, beginning with Delhi and Mumbai.
The sixth edition of the annual runway spectacle will return to the US after this year's outing in Milan.
Congestion at ports in Asia combined with weaker demand across Europe and emerging markets from the war hurt sales, the company said.
Towle, known for sharing her life as a young woman living with cancer, passed away aged 26 on Wednesday.
Strong sales among young and affluent shoppers helped drive quarterly revenue above analysts' expectations.
The US consumer health company and parent of Neutrogena narrowly missed Wall Street estimates for second-quarter results as tariffs and currency-related costs offset sales gains.